TP53 and cancer: Notably, cancer cells carrying dysfunctional p53 show the partial conversion to fetal phenotype but fail to acquire a functional PQL phenotype, as they lose TIC associated with massive accumulation of DNA damage, when treated at doses that reduce cell growth ~20–30 %.